G, K., S, A., PS, P., RD, L., UD, P., G, L., . . . KW, M. (2026). Adjudicating Heart Failure Events in Participants Receiving Hemodialysis: Findings from Evaluation of Cinacalcet Hydrochloride Therapy to Lower Cardiovascular Events (EVOLVE) Trial. American journal of nephrology, 1. https://doi.org/10.1159/000553103
Chicago Style (17th ed.) CitationG, Kang, Abdalla S, Parfrey PS, Lopes RD, Patel UD, London G, Chertow GM, and Mahaffey KW. "Adjudicating Heart Failure Events in Participants Receiving Hemodialysis: Findings from Evaluation of Cinacalcet Hydrochloride Therapy to Lower Cardiovascular Events (EVOLVE) Trial." American Journal of Nephrology 2026: 1. https://doi.org/10.1159/000553103.
MLA (9th ed.) CitationG, Kang, et al. "Adjudicating Heart Failure Events in Participants Receiving Hemodialysis: Findings from Evaluation of Cinacalcet Hydrochloride Therapy to Lower Cardiovascular Events (EVOLVE) Trial." American Journal of Nephrology, 2026, p. 1, https://doi.org/10.1159/000553103.